Prestige Consumer Healthcare, Inc. (PBH)
51.78
-0.69
(-1.32%)
USD |
NYSE |
Aug 31, 16:00
51.80
+0.02
(+0.04%)
After-Hours: 20:00
Prestige Consumer Healthcare Total Long Term Debt (Quarterly) : 2.057B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.057B |
| March 31, 2026 | 1.036B |
| December 31, 2025 | 1.073B |
| September 30, 2025 | 1.035B |
| June 30, 2025 | 1.037B |
| March 31, 2025 | 1.038B |
| December 31, 2024 | 1.021B |
| September 30, 2024 | 1.058B |
| June 30, 2024 | 1.099B |
| March 31, 2024 | 1.135B |
| December 31, 2023 | 1.208B |
| September 30, 2023 | 1.273B |
| June 30, 2023 | 1.329B |
| March 31, 2023 | 1.360B |
| December 31, 2022 | 1.441B |
| September 30, 2022 | 1.457B |
| June 30, 2022 | 1.493B |
| March 31, 2022 | 1.500B |
| December 31, 2021 | 1.555B |
| September 30, 2021 | 1.625B |
| June 30, 2021 | 1.572B |
| March 31, 2021 | 1.509B |
| December 31, 2020 | 1.580B |
| September 30, 2020 | 1.582B |
| June 30, 2020 | 1.650B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.761B |
| December 31, 2019 | 1.733B |
| September 30, 2019 | 1.782B |
| June 30, 2019 | 1.792B |
| March 31, 2019 | 1.799B |
| December 31, 2018 | 1.842B |
| September 30, 2018 | 1.896B |
| June 30, 2018 | 1.994B |
| March 31, 2018 | 1.993B |
| December 31, 2017 | 2.053B |
| September 30, 2017 | 2.092B |
| June 30, 2017 | 2.145B |
| March 31, 2017 | 2.194B |
| December 31, 2016 | 1.416B |
| September 30, 2016 | 1.480B |
| June 30, 2016 | 1.577B |
| March 31, 2016 | 1.625B |
| December 31, 2015 | 1.447B |
| September 30, 2015 | 1.472B |
| June 30, 2015 | 1.515B |
| March 31, 2015 | 1.589B |
| December 31, 2014 | 1.638B |
| September 30, 2014 | 1.692B |
| June 30, 2014 | 969.56M |
| March 31, 2014 | 934.41M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 500.00M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |
| Johnson & Johnson | 37.34B |